Tenax Therapeutics Stock Price - TENX

1.22
0.0199 (1.66%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Tenax Therapeutics Inc TENX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0201 1.7% 1.2001 1.175 1.25 1.19 1.18 18:29:37
Bid Price Ask Price Spread Spread % News
1.20 2.50 1.30 52.0% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
115 25,380 $ 1.21 $ 30,669 44,536 1.10 - 2.79
Last Trade Time Type Quantity Stock Price Currency
15:59:37 68 $ 1.22 USD

Tenax Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 8.09M 6.74M $ -6.81M -9.03 - 5.12M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 24.00%

more financials information »

Tenax Therapeutics News

Loading Messages....

Latest TENX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TENX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.261.271.161.1931,133-0.0599-4.75%
1 Month1.281.561.161.3341,925-0.0799-6.24%
3 Months1.151.561.131.3041,0990.05014.36%
6 Months1.2251.741.101.2649,853-0.0249-2.03%
1 Year1.182.791.101.78341,5760.02011.7%
3 Years13.8016.8161.036.14367,257-12.60-91.3%
5 Years64.0079.601.0311.91296,170-62.80-98.12%

Tenax Therapeutics Description

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The company develops novel product candidates such as Levodimendan IV that have the potential to address various critical care conditions with a high unmet medical need. Its drugs help in the reduction of morbidity and mortality in cardiac surgery patients. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure.


Your Recent History
NASDAQ
TENX
Tenax Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.